Here, we investigate the role of CK2 in CKD-MBD and elucidate a potential mechanistic basis by which CK2 alleviates CKD-MBD through interactions with RUNX2 and USP7. The gene discussed is RUNX2; the disease is Marchiafava-Bignami disease.